tiprankstipranks
SpringWorks Therapeutics reports Q3 EPS (72c), consensus (75c)
PremiumThe FlySpringWorks Therapeutics reports Q3 EPS (72c), consensus (75c)
8d ago
SpringWorks Therapeutics announces data on mirdametinib
Premium
The Fly
SpringWorks Therapeutics announces data on mirdametinib
9d ago
SpringWorks Therapeutics’ mirdametinib shows efficacy in neurofibromatosis study
Premium
The Fly
SpringWorks Therapeutics’ mirdametinib shows efficacy in neurofibromatosis study
9d ago
SpringWorks Therapeutics price target raised to $76 from $74 at H.C. Wainwright
PremiumThe FlySpringWorks Therapeutics price target raised to $76 from $74 at H.C. Wainwright
3M ago
SpringWorks Therapeutics reports Q2 EPS (54c), consensus ($1.11)
Premium
The Fly
SpringWorks Therapeutics reports Q2 EPS (54c), consensus ($1.11)
4M ago
SpringWorks Therapeutics Appoints Martin Mackay as Director
Premium
Company Announcements
SpringWorks Therapeutics Appoints Martin Mackay as Director
4M ago
3 Best Stocks to Buy Now, 5/3/2024, According to Top Analysts 
PremiumMarket News3 Best Stocks to Buy Now, 5/3/2024, According to Top Analysts 
7M ago
SpringWorks Therapeutics reports Q1 EPS ($1.18), consensus ($1.18)
Premium
The Fly
SpringWorks Therapeutics reports Q1 EPS ($1.18), consensus ($1.18)
7M ago
SpringWorks Therapeutics price target raised to $74 from $73 at JPMorgan
Premium
The Fly
SpringWorks Therapeutics price target raised to $74 from $73 at JPMorgan
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100